[Ortho] Два протеза или .........?

[Середа Андрей]

> Но как выжавают короткие ножки.? Вопрос на колокольню разновеликих
>  эндопротезистов.
>
На то есть обзор.

Hip Int. <http://www.ncbi.nlm.nih.gov/pubmed/22878970#> 2012
Jul-Aug;22(4):344-54. doi: 10.5301/HIP.2012.9472.
Survival of short hip stems with a "modern", trochanter-sparing design - a
systematic literature review.
Rometsch E<http://www.ncbi.nlm.nih.gov/pubmed?term=Rometsch%20E%5BAuthor%5D&cauthor=true&cauthor_uid=22878970>
, Bos PK<http://www.ncbi.nlm.nih.gov/pubmed?term=Bos%20PK%5BAuthor%5D&cauthor=true&cauthor_uid=22878970>
, Koes BW<http://www.ncbi.nlm.nih.gov/pubmed?term=Koes%20BW%5BAuthor%5D&cauthor=true&cauthor_uid=22878970>
.
Source

Department of Orthopaedics, Erasmus Medical Centre, Rotterdam, The
Netherlands. clinicalscience.er на gmail.com
Abstract

Modern total hip arthroplasty delivers excellent and reproducible results.
New implant developments include a wide range of implants with a bone and
tissue sparing design, including short femoral stems. This review was
performed to provide an overview on the currently published survival
results of short stems to allow comparison with the results of traditional
hip stems. A literature search was performed to identify publications on
short stems with a "modern" trochanter sparing design including implant
survival information. Information was collected on the study population,
follow-up time, implants used, implant survival and functional scores. The
revision rate per 100 observed component years was calculated and compared
to data presented in national arthroplasty registries. The methodological
quality was assessed by employing a score specific to survival assessment
of hip stems. In the course of 16 individual searches in EMBASE and
Medline, 460 potentially eligible articles were identified. After thorough
screening, 14 articles were deemed applicable. The variability in quality
of the publications was high. No association between survival outcome and
publication quality was apparent. The total revision rate over all studies
was found to be 0.38 per 100 component years with endpoint "stem revision
for any reason". The survival rate of these stems is encouraging and
appears to be comparable with that of more traditional uncemented stems.
However, only few mid-term and long-term studies are available. Reports
with longer follow-up are needed to draw further conclusions.


-- 
C уважением, Середа Андрей Петрович.
Sereda Andrey, MD, PhD, orthopaedic surgeon,
I.M. Sechenov First Moscow State Medical University, Orthopaedic
department, Deputy Director for Science.
6, Bolshaya Pirogovskaya street
119991, Moscow, Russia
*P** **Пожалуйста, не распечатывайте электронные письма и документы без
реальной необходимости - берегите природу.*

*P** **Please consider the environment before printing this e-mail** **or
attached document**.** **Moreover what you have print is not you have
thought about. *
----------- следущая часть -----------
Вложение в формате HTML было извлечено&hellip;
URL: http://weborto.net:8080/pipermail/ortho/attachments/20130611/b81909de/attachment-0001.htm